In contrast, siRNA-targeted ADAM10 downregulation was reported to suppress cell proliferation of hepatocellular carcinoma [8], bladder cancer [7] and nasopharyngeal carcinoma [10] cells. This evidence concerns the gene ADAM10 and urinary bladder cancer.